References
- Berghout LM, Gorter KJ, Rutten GEHM. Improvement of glycaemic control without exogenous insulin in 40% of poorly regulated patients with type 2 diabetes mellitus; a study in 18 Dutch general practices. Ned Tijdschr Geneeskd 2001;145:2035–9 (abstract in English).
- Goudswaard AN, Stolk RP, Valk HW de, Rutten GEHM. Improving glycaemic control in patients with type 2 diabetes mellitus without insulin. Diabet Med 2003; 20: 540–4
- Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999; 281: 2005–12
- Goudswaard AN, Stolk RP, Zuithoff NPA, Valk HW de, Rutten GEHM. Starting insulin therapy in patients with type 2 diabetes: with or without continuation of oral hypoglycaemic agents? A randomized trial in primary care. J Fam Pract 2004; 53: 393–9
- Hayward RA, Manning WG, Kaplan SH, Wagner EH, Greenfield S. Starting insulin therapy in patients with type 2 diabetes. JAMA 1997; 278: 1663–700
- Dunn NR, Bough P. Standards of care of diabetic patients in a typical English community. Br J Gen Pract 1996; 46: 401–5
- Wiersma TJ, Heine RJ, Rutten GEHM. [Summary of the practice guideline “Diabetes mellitus type 2” (first revision) of the Dutch College of General Practitioners]. Ned Tijdschr Geneeskd 1999; 143: 1688–91
- Grimes DA, Schulz KF. Cohort studies: marching towards outcomes. Lancet 2002; 359: 341–5
- Cefalu WT. Evaluation of alternative strategies for optimizing glycemia: progress to date. Am J Med 2002; 113: 23S–35S
- UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53